Comparison of 5 flow cytometric immunophenotyping systems for absolute CD4+ T-lymphocyte counts in HIV-1-infected patients living in resource-limited settings

Journal of Acquired Immune Deficiency Syndromes

Volumn 49, Issue 4, 2008, Pages 339-347

  Pattanapanyasat, Kovit ^a,b   Phuang Ngern, Yuwadee ^b   Sukapirom, Kasama ^a   Lerdwana, Surada ^a   Thepthai, Charin ^b   Tassaneetrithep, Boonrat ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

AIDS; CD4 T lymphocyte count; Flow cytometry; HIV; Single platform

Indexed keywords

ARTICLE; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOPHENOTYPING; METRIC SYSTEM; PRIORITY JOURNAL; THAILAND; VOLUMETRY;

CD4 LYMPHOCYTE COUNT; FLOW CYTOMETRY; HEALTH CARE COSTS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOPHENOTYPING; LINEAR MODELS; POVERTY; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 57649121790     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31818c1721     Document Type: Article

References (30)

1. WHO. Emergency scale-up of antiretroviral therapy in resource-poor settings: technical operational recommendations to achieve 3 by 5. 2004. Available at: http://www.who.int/3by5/publications/documents/Zambia/en/index. html. Accessed November 20, 2007.
2. UNAIDS. Opening statement, CONCASIDA 2007. 2007. Available at: http://data.unaids.org/Pub/SpeechEXD/20071107_sp_piot_concasida_en.pdf. Accessed November 20, 2007.
3. WHO/UNAIDS. Progress on Global Access to HIV Antiviral Therapy: A Report on "3 by 5" and Beyond. Geneva, Switzerland: World Health Organization (WHO) and United Nations Program on HIV/AIDS (UNAIDS); March 2006. Available at: http://www.who.int/hiv/fullreport_en_highres.pdf. Accessed November 20, 2007.
4. Fahey JL, Taylor JMG, Detels R, et al. The prognostic value of cellular and serologic markers in infaction with human immunodeficiency virus type 1. N Eng J Med. 1990;322:166-172.
5. Fauci AS, Macher AM, Longo DL, Detels R, et al. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic consideration. Ann Intern Med. 1984;100:92-106.
6. Giorgi JV, Detels R. T-cell subset alterations in HIV-infected homosexual men: NIAID Multicenter AIDS cohort study. Clin Immunol Immunopathol. 1989;52:10-18.
7. Centers for Disease Control and Prevention. Revised guidelines for performing CD4+ T-cell determinations in persons infected with human immunodeficiency virus (HIV). MMWR Morb Mortal Wkly Rep. 1997;46:1-29.
8. National Committee for Clinical Laboratory Standards (NCCLS). ClinicalApplication of Flow Cytometry: Immunophenotyping of Lymphocytes. Approved Guideline. Wayne, PA. NCCLS Document H42A; 1998.
9. Centers for Disease Control and Prevention. Guidelines for performing single-platform absolute CD4+ T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep. 2003;52(RR-02):1-13.
10. Nicholson JKA, Jones BM, Hubbard M. CD4 T-lymphocyte determinations on whole blood specimens using a single-tube three-color assay. Cytometry. 1993;14:685-689.
11. Malone JL, Simms TE, Gray GC, et al. Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1 infected patients: total lymphocyte count fluctuation and diurnal cycle are important. J Acquir Immune Defic Syndr. 1990;3:144-151.
12. Robinson G, Morgan L, Evans M, et al. The effect of type of hematology analyzer on CD4+ count. Lancet. 1992;340:485.
13. Brando B, Barnett D, Janossy G, et al. Cytofluorometric methods for assessing absolute numbers of cells in blood. For the European Working Party on Clinical Cell Analysis (EWGCCA). Cytometry. 2000;42:327-346.
14. Whitby L, Granger V, Storie I, et al. Quality control of CD4+ T-lymphocyte enumeration: results from the 9 years of the United Kingdom national external quality assessment scheme for immune monitoring (1993-2001). Cytometry. 2002;50:102-110.
15. Strauss K, Hannet I, Engels S, et al. Performance evaluation of the FACSCount system: a dedicated system for clinical cellular analysis. Cytometry. 1996;26:52-59.
16. Cassens U, Gohde W, Kuling G, et al. Simplified volumetric flow cytometry allows feasible and accurate determination of CD4 T lymphocytes in immunodeficient patients worldwide. Antivir Ther. 2004;9:395-405.
17. Dieye TN, Vereecken C, Diallo AA, et al. Absolute CD4 T-cell counting in resource-poor settings: direct volumetric measurements versus bead-based clinical flow cytometry instruments. J Acquir Immune Defic Syndr. 2005;39:32-37.
18. green) for enumeration of absolute CD4+ T lymphocytes in human immunodeficiency virus type 1-infected Thai patients. Clin Diagn Lab Immunol. 2005;12:1416-1424.
19. Pattanapanyasat K, Phuang-Ngern Y, Lerdwana S, et al. Evaluation of a single-platform microcapillary flow cytometer for enumeration of absolute CD4+ T-lymphocyte counts in HIV-1 infected Thai patients. Cytometry B (Clin Cytom). 2007;72B:387-396.
20. Guava Technologies Celebrates Tenth Anniversary. A Decade of Helping Scientists and Clinicians Understand Life One Cell at a Time. Guava Technologies Inc; 2008. Available at: http://guavatechnologies.com/Library/ downloads/News/PR-020608TenYrAnn.pdf.pdf. Accessed March 17, 2007.
21. Increasing success for patient programmes due to CyFlow CD4 counting technology. Partec GmbH. Available at: http://www.partec.com/preview/cms/ frpnt_content.php?idart=455. Accessed March 17, 2008.
22. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310.
23. Scott LE, Galpin JS, Glencross DK. Multiple method comparison: statistical model using percentage similarity. Cytometry B (Clin Cytom). 2003;54B:46-53.
24. Kandathil AJ, Kannangai R, David S, et al. Comparison of microcapillary cytometry technology and flow cytometry for CD4+ and CD8+ T-cell estimation. Clin Diagn Lab Immunol. 2005;12:1006-1009.
25. Balakrishnan P, Solomon S, Mohanakrishnan J, et al. A reliable and inexpensive EasyCD4 assay for monitoring HIV-infected individuals in resource-limited settings. J Acquir Immune Defic Syndr. 2006;43:23-26.
26. Lynen L, Teav S, Vereecken C, et al. Validation of primary CD4 gating as an affordable strategy for absolute CD4 counting in Cambodia. J Acquir Immune Defic Syndr. 2006;43:179-185.
27. Manasa J, Musabaike H, Masimirembwa C, et al. Evaluation of the Partec flow cytometer against the BD FACSCalibur system for monitoring immune responses of human immunodeficiency virus-infected patients in Zimbabwe. Clin Vaccine Immunol. 2007;14:293-298.
28. Brando B, Gohde W Jr, Scarpati B, et al. The "vanishing counting bead" phenomenon: effect on absolute CD34+ cell counting in phosphate-buffered saline-diluted leukapheresis samples. Cytometry. 2001;43:154-160.
29. Bossuyt X, Marti GE, Fleisher TA. Comparative analysis of whole blood lysis methods for flow cytometry. Cytometry. 1997;30:124-133.
30. Gratama JW, van der Linden R, van der Holt B, et al. Analysis of factors contributing to the formation of mononuclear cell aggregates ("escapees") in flow cytometric immunophenotyping. Cytometry. 1997;29:250-260.